“I feel I can live every minute if I choose to”: participants’ experience of a positive mindfulness programme

Both separately and together, mindfulness and positive psychological interventions have been found to increase wellbeing against a number of measures. Research has been primarily based on the application of self-report scales, and little has been done to examine the lived experience of participants. The aim of this study was to apply an interpretative phenomenological approach to the experience of participants in a Mindfulness Based Flourishing (MBF) programme, which combines positive psychological interventions with mindfulness in order to more fully understand the impact of their experience on them. Three participants from a completed MBF programme each had a one-off semi-structured interview, the results of which were transcribed verbatim. The resulting texts were analysed, with five themes emerging, which demonstrated the impact of the programme on participants’ sense of self and on the nature of their connections with others. While all participants identified benefits accruing from the course, it also presented challenges emotionally as well as in terms of the embedding of knowledge and skills. Future research should look to examine the impact of such programmes in wider cultural and temporal frameworks and should explore the application of grounded theory to identify more theoretical level explanations of the phenomenon.     

Affect and emotions in placebo and nocebo effects: What do we know so far?

Once considered nuisance variance in clinical trials, placebo effects and nocebo effects are now widely recognized as important and mutable psychobiological contributors to mental and physical health. Psychological theory explaining these effects emphasizes associative learning and conscious expectations. It has long been suggested, however, that affective states such as moods, emotions, and distress could play a significant role. In this paper, we draw together and review the empirical data linking affective states to placebo and nocebo effects. To organize this disparate literature, three questions are addressed: (1) Does pre‐existing state and trait affect modulate placebo and nocebo effects? (2) Does administering placebo and nocebo treatments change affective states, and if so, does the resulting affect causally influence placebo and nocebo effects? Finally, (3) Can placebo treatments be successfully employed as a regulation strategy to modulate different affective states? In reviewing the evidence in relation to these three questions, it is clear that affect does play a key role in placebo and nocebo effects in many circumstances, and further, there may be a reciprocal dynamic at play between a treatment event, affect, and placebo/nocebo effects. The paper concludes by discussing implications for theory and intervention and recommends future research priorities.